Thu, August 16, 2018
Wed, August 15, 2018
Tue, August 14, 2018
Mon, August 13, 2018
Fri, August 10, 2018
Thu, August 9, 2018
Wed, August 8, 2018
Tue, August 7, 2018
Mon, August 6, 2018
Fri, August 3, 2018
Thu, August 2, 2018

Robyn Karnauskas Maintained (BMRN) at Strong Buy with Increased Target to $120 on, Aug 9th, 2018


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-120-on-aug-9th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Robyn Karnauskas of Citigroup, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Increased Target from $108 to $120 on, Aug 9th, 2018.

Robyn has made no other calls on BMRN in the last 4 months.



There are 7 other peers that have a rating on BMRN. Out of the 7 peers that are also analyzing BMRN, 1 agrees with Robyn's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Increased Target to $98 on, Monday, August 6th, 2018


These are the ratings of the 6 analyists that currently disagree with Robyn


  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $120 on, Monday, August 6th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $115 on, Friday, August 3rd, 2018
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Increased Target to $109 on, Friday, August 3rd, 2018
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $113 on, Tuesday, July 31st, 2018
  • M. Auster of "Credit Suisse" Maintained at Buy with Increased Target to $122 on, Monday, July 9th, 2018
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $133 on, Thursday, May 31st, 2018

Publication Contributing Sources